Schrenk D, Bignami M, Bodin L, Chipman JK, Mazo JD, Grasl-Kraupp B, et al. Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA J. 2020;18:e06223.

CAS  PubMed  PubMed Central  Google Scholar 

Ahrens L, Bundschuh M. Fate and effects of poly- and perfluoroalkyl substances in the aquatic environment: a review. Environ Toxicol Chem. 2014;33:1921–9.

Article  CAS  PubMed  Google Scholar 

Girardi P, Merler E. A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid. Environ Res 2019;179:108743.

Article  CAS  PubMed  Google Scholar 

Trowbridge J, Gerona RR, Lin T, Rudel RA, Bessonneau V, Buren H. et al. Exposure to perfluoroalkyl substances in a cohort of women firefighters and office workers in San Francisco. Environ Sci Technol. 2020;54:3363–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papadopoulou E, Sabaredzovic A, Namork E, Nygaard UC, Granum B, Haug LS. Exposure of Norwegian toddlers to perfluoroalkyl substances (PFAS): The association with breastfeeding and maternal PFAS concentrations. Environ Int. 2016;94:687–94.

Article  CAS  PubMed  Google Scholar 

Schaider LA, Balan SA, Blum A, Andrews DQ, Strynar MJ, Dickinson ME, et al. Fluorinated compounds in U.S. fast food packaging. Environ Sci Technol Lett. 2017;4:105–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winkens K, Giovanoulis G, Koponen J, Vestergren R, Berger U, Karvonen AM, et al. Perfluoroalkyl acids and their precursors in floor dust of children’s bedrooms - Implications for indoor exposure. Environ Int. 2018;119:493–502.

Article  CAS  PubMed  Google Scholar 

Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75:46–51.

Article  CAS  PubMed  Google Scholar 

Li Y, Barregard L, Xu Y, Scott K, Pineda D, Lindh CH, et al. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water. Environ Health. 2020;19:33.

Article  PubMed  PubMed Central  Google Scholar 

Papadopoulou E, Nicolescu A, Haug LS, Husøy T, Deleanu C, Dirven H, et al. Lipoprotein profiles associated with exposure to poly- and perfluoroalkyl substances (PFASs) in the EuroMix human biomonitoring study. Environ Pollut. 2022;308:119664.

Article  CAS  PubMed  Google Scholar 

Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, et al. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiology. 2013;24:569–76.

Article  PubMed  PubMed Central  Google Scholar 

Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 2014;98:78–83.

Article  CAS  PubMed  Google Scholar 

Liu H-S, Wen L-L, Chu P-L, Lin C-Y. Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013–2014. Environ Pollut. 2018;232:73–9.

Article  CAS  PubMed  Google Scholar 

Zeng X-W, Qian Z, Emo B, Vaughn M, Bao J, Qin X-D, et al. Association of polyfluoroalkyl chemical exposure with serum lipids in children. Sci Total Environ. 2015;512-513:364–70.

Article  CAS  PubMed  Google Scholar 

Blomberg AJ, Shih Y-H, Messerlian C, Jørgensen LH, Weihe P, Grandjean P. Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort. Environ Res. 2021;200:111400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunder L, Lind PM, Salihovic S, Stubleski J, Kärrman A, Lind L. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years. Environ Res. 2022;211:112903.

Article  CAS  PubMed  Google Scholar 

Lin P-ID, Cardenas A, Hauser R, Gold DR, Kleinman KP, Hivert M-F, et al. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults—longitudinal analysis of the diabetes prevention program outcomes study. Environ Int. 2019;129:343–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canova C, Barbieri G, Zare Jeddi M, Gion M, Fabricio A, Daprà F, et al. Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region. Environ Int. 2020;145:106117.

Article  CAS  PubMed  Google Scholar 

Fenton SE, Ducatman A, Boobis A, DeWitt JC, Lau C, Ng C, et al. Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem. 2021;40:606–30.

Article  CAS  PubMed  Google Scholar 

Averina M, Brox J, Huber S, Furberg A-S. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study. Environ Res. 2021;195:110740.

Article  CAS  PubMed  Google Scholar 

Lind L. Relationships between three different tests to evaluate endothelium-dependent vasodilation and cardiovascular risk in a middle-aged sample. J Hypertens. 2013;31:1570–4.

Article  CAS  PubMed  Google Scholar 

Salihovic S, Kärrman A, Lindström G, Lind PM, Lind L, van Bavel B. A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry. J Chromatogr A. 2013;1305:164–70.

Article  CAS  PubMed  Google Scholar 

Gyllenhammar I, Berger U, Sundström M, McCleaf P, Eurén K, Eriksson S, et al. Influence of contaminated drinking water on perfluoroalkyl acid levels in human serum-A case study from Uppsala, Sweden. Environ Res. 2015;140:673–83.

Article  CAS  PubMed  Google Scholar 

Stubleski J, Salihovic S, Lind PM, Lind L, Dunder L, McCleaf P, et al. The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort. Environ Res. 2017;159:95–102.

Article  CAS  PubMed  Google Scholar 

Liu G, Zhang B, Hu Y, Rood J, Liang L, Qi L, et al. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study. Environ Health. 2020;19:5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu Y, Wang T, Fu Q, Wang P, Lu Y. Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population. Ecotoxicol Environ Saf. 2014;106:246–52.

Article  CAS  PubMed  Google Scholar 

Koba S, Yokota Y, Hirano T, Ito Y, Ban Y, Tsunoda F, et al. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb. 2008;15:250–60.

Article  CAS  PubMed  Google Scholar 

Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, Goff DC, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2007;192:211–7.

Article  CAS  PubMed  Google Scholar 

Feingold KR Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.

Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep. 2004;6:381–7.

Article  PubMed  Google Scholar 

Ip S, Lichtenstein AH, Chung M, Lau J, Balk EM. Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med. 2009;150:474–84.

Article  PubMed  PubMed Central  Google Scholar 

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–78.

Article  CAS  PubMed  Google Scholar 

Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71:620–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng X, Long G, Zeng G, Zhang Q, Song B, Wu K-H. Association of increased risk of cardiovascular diseases with higher levels of perfluoroalkylated substances in the serum of adults. Environ Sci Pollut Res Int. 2022;29:89081–92.

Wen X, Wang M, Xu X, Li T. Exposure to per- and polyfluoroalkyl substances and mortality in U.S. Adults: a population-based cohort study. Environ Health Perspect. 2022;130:67007.

Article  CAS  PubMed  Google Scholar 

Schillemans T, Donat-Vargas C, Lindh CH, de Faire U, Wolk A, Leander K, et al. Per- and polyfluoroalkyl substances and risk of myocardial infarction and stroke: a nested case-control study in Sweden. Environ Health Perspect. 2022;130:37007.

Article